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Introduction
Mechanical ventilation is a frequently applied and often life–saving 
strategy in critically ill patients [1]. Paradoxically, ventilation itself has 
the potential to worsen preexisting lung injury or even cause lung injury 
[2]. Ventilation–associated lung injury is suggested to result, at least in 
part through overstretching of aerated lung tissue and tidal recruitment 
of collapsed lung parts [2]. So-called ‘protective ventilation’ with lower 
tidal volumes (i.e., tidal volumes of 6 ml/kg Predicted Body Weight 
(PBW)) aiming at prevention of overstretching of lung tissue is strongly 
associated with reduced morbidity and mortality of Intensive Care Unit 
(ICU) patients with the Acute Respiratory Distress Syndrome (ARDS) 
[3-6], and consequently recommended in international guidelines [7].
Results from one multi–center randomized controlled trial suggest 
that ICU patients without ARDS could also benefit from protective 
ventilation with lower tidal volumes [8]. A recent meta–analysis 
confirmed such claim, showing an increased incidence of pulmonary 
complications and even increased mortality in patients who receive 
‘higher’ or ‘traditionally-sized tidal volumes’ (i.e., tidal volumes of >10 
Abstract
Background: Use of lower tidal volumes during mechanical ventilation is associated with reduced morbidity and 
mortality of Intensive Care Unit (ICU) patients with the Acute Respiratory Distress Syndrome (ARDS). Use of lower tidal 
volumes could also protect ICU patients without ARDS. While use of higher tidal volumes is strongly discouraged in 
ARDS patients, guidelines do not yet recommend on tidal volume size in patients not suffering from this complication, 
resulting in unwanted variable mechanical ventilation settings amongst ICU patients. 
Purpose: The present study aims to determine ventilation characteristics, including tidal volume size in intubated 
and mechanically ventilated patients in ICUs in Europe, Australia and the Americas. Ventilation characteristics and 
outcomes are compared among patients without ARDS, patients at risk for ARDS and patients with mild, moderate or 
severe ARDS. 
Methods: The ‘PRatice of VENTilation in critically ill patients without ARDS’ study (PRoVENT) is an international 
multicenter observational study in critically ill intubated and ventilated ICU patients by the PROVENet (PROtective 
VENtilation Network) investigators (http://www.provenet.eu/). At least 1,000 patients under invasive mechanical 
ventilation are included in a time window of 7 days, and followed up to the end of stay in ICU. The primary endpoint is 
the variability of tidal volume size in ventilated patients in ICUs in Europe, Australia and the Americas.
Conclusion: PRoVENT is designed to investigate and compare tidal volume settings in patients without ARDS, 
patients at risk for ARDS, and patients with mild, moderate or severe ARDS, and to determine the impact of tidal 
volume size on important clinical endpoints, in particular patients without ARDS. PRoVENT shall provide information on 
ventilator settings that could be used in future trials of ventilation, especially in ICU patients without or at risk for ARDS 
(Trial Registration: NCT01868321).
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ml/kg PBW) [9]. Whether we should use lower tidal volumes in ICU 
patients without ARDS remains debatable, since such measure can 
increase the need for sedation and prolonged use of muscle paralysis, 
possibly increasing the incidence of delirium, critical illness-associated 
muscle weakness, and even diaphragm dysfunction [10]. In view of the 
lack of evidence, guidelines inconsistently advise on tidal volume size 
in ICU patients without ARDS.
In view of those facts, a large well-powered randomized controlled 
trial comparing ventilation with lower tidal volumes with ‘conventional 
ventilation’ using traditionally-sized tidal volumes is needed to answer 
the question whether ICU physicians should use lower tidal volumes 
in all ventilated patients, including those without ARDS. Such a trial 
should not only use relevant clinical endpoints and pay attention to 
safety of use of lower tidal volumes, but also compare a lower tidal 
volume strategy to relevant tidal volumes in the control arm. Indeed, 
lower tidal volumes are increasingly used [3-6], possibly even in 
patients without ARDS in whom the benefits of lower tidal volumes are 
less certain. If studies of current practice would show that tidal volumes 
of >10 ml/kg PBW by now are uncommon, a conventional ventilation 
arm using tidal volumes of that size may impose a significant health 
risk of patients in that group, and also may hamper valorization of the 
trial results.
The PRatice of VENTilation in critically ill patients without 
ARDS (PRoVENT) study aims to determine ventilation practice and 
outcomes of intubated and ventilated ICU patients. PRoVENT shall 
provide information on ventilator settings that can be used in future 
trials of mechanical ventilation, in particular in patients without or at 
risk for ARDS.
 Methods
Design
The PRoVENT study is an international multicenter observational 
study. The Institutional Review Board of the Academic Medical 
Center at the University of Amsterdam, Amsterdam, The Netherlands, 
approved the study and analysis plan. PRoVENT is conducted in 
accordance with the declaration of Helsinki and is registered at www.
clinicaltrials.gov (trial identification number NCT01868321). Due 
to the strict observational design and anonymous collection of data, 
informed consent is not needed in most countries-however; in certain 
countries individual patient informed consent is required according to 
local IRB regulations. Figure 1 and 2 shows the CONSORT diagram of 
PRoVENT.
 ICU: Intensive Care Unit; ARDS: Acute Respiratory Distress Syndrome; TTW: Three Times a Week
Figure 1: Flowchart of inclusion of PRoVENT.
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Study population
Inclusion is not restricted to patients who are intubated for 
mechanical ventilation in the ICU; Patients who started mechanical 
ventilation in the emergency room, ward, community or operating 
room before the present ICU admission are also eligible for participation 
and should be included. Age <18 years, use of only non-invasive 
ventilation not followed by invasive ventilation, patients under invasive 
mechanical ventilation previous to the 7-day period of inclusion, and 
patients transferred from another hospital under invasive mechanical 
ventilation represent the main exclusion criteria (Table 1).
Patients are stratified in three groups for comparison of the primary 
and secondary endpoints: patients without ARDS, patients without, 
but at risk for development of ARDS (defined as a LIPS ≥ 4 points), 
and patients with ARDS. Also, patients with ARDS will be stratified 
according to severity of ARDS (mild, moderate and severe).
Study conduct
Local investigators will screen all patients admitted to participating 
ICUs during a 7-day period. This period of inclusion of patients lasts 
from Monday at 8:00 AM to the next Monday at 7:59 AM (in time 
zones of the participating centers), the starting date will be flexible for 
participating centers and shall be determined at a later stage together 
with the study coordinator.
Baseline and demographic data on all screened patients, regardless 
of meeting enrolment criteria are recorded (see below).
Data collection
Baseline and demographic variables are collected on the day of 
admission, including gender, age, height, weight, ethnicity, smoker 
(never, former or current), functional status (non-dependent, partially 
dependent, totally dependent), presence of ARDS according to Berlin 
definition (Table 2) [11], Lung Injury Prediction Score (LIPS) (Table 
3) [12], Acute Physiology And Chronic Health Evaluation (APACHE 
II) score, Simplified Acute Physiology (SAPS III) score, reason for ICU 
admission, and reason for intubation and ventilation. In addition, it 
is determined whether patients have Chronic Obstructive Pulmonary 
Disease (COPD) with use of inhalation therapy and/or steroids, active 
cancer, heart failure, according to the New York Heart Association 
(NYHA), diabetes mellitus, chronic kidney failure with or without 
hemodialysis, liver cirrhosis, immunosuppression, and arterial 
hypertension. On the day of start of invasive ventilation the reason 
for mechanical ventilation is collected, as well as whether the patient 
received non-invasive ventilation before intubation.
Every day, until ICU discharge, death or day 7 (whichever comes 
first), patients are evaluated according to ventilation status (extubation 
or not), continuation of ventilation by non-invasive ventilation, 
 CRF: Case Report Form
Figure 2: Flowchart of follow-up of PRoVENT.
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tracheostomy, and mortality. Ventilation parameters (ventilation 
mode, tidal volume size, respiratory rate, peak and plateau [with 
volume-controlled modes] or maximum airway pressure [with 
pressure-controlled modes], Positive End-Expiratory Pressure (PEEP), 
inspired oxygen fraction, inspiration to expiration ratio, minute 
volume), oxygenation parameters (PaO2, PaCO2, arterial bicarbonate, 
arterial pH, arterial base excess, end-tidal fraction of CO2), vital signs 
(heart rate, cardiac rhythm, blood pressure, central venous pressure), 
transfusion requirements (red blood cell, fresh frozen plasma and 
platelets), daily fluid balance, sedation scores (RASS, SAS or Ramsay), 
and Sequential Organ Failure Assessment (SOFA) subgroups (cardiac, 
hepatic, respiratory, coagulation, kidney and neurologic) are recorded 
every day close to 08:00 AM until ICU discharge, death or day 7 
(whichever comes first).
Pulmonary complications (new requirement of invasive ventilation, 
pulmonary infection, atelectasis, barotrauma, pleural effusion, new 
pulmonary infiltrates, and development or worsening of ARDS), and 
extrapulmonary complications (sepsis, extra-pulmonary infection, 
acute kidney injury and renal replacement therapy) are recorded daily 
until ICU discharge, death or day 7 (whichever comes first) and on ICU 
and hospital discharge. 
On day 90, hospital-free days, ICU-free days, ventilation-free days, 
need of tracheostomy and mortality are recorded; if the patient is still 
admitted to the hospital on day 90, this day will be recorded as last day 
of follow-up.
Study endpoints
The primary endpoint is the variability of size of tidal volumes used 
amongst diverse ICU patient categories. Secondary clinical endpoints 
include: 1) other ventilation parameters (including plateau pressure 
levels, PEEP levels, and driving pressure levels); 2) development 
of ARDS in patients without ARDS at the onset of mechanical 
ventilation; 3) worsening of ARDS in patients with ARDS at the onset 
of mechanical ventilation; 4) pulmonary infection; 5) other pulmonary 
complications (barotrauma, pleural effusion and atelectasis); 5) need 
for tracheostomy; 6) extra-pulmonary complications (acute kidney 
INCLUSION CRITERIA
1. Admitted to a participant ICU
2. Intubated in the participating ICU, ER, ward, community or before the present ICU admission
EXCLUSION CRITERIA
1. Age < 18 year
2. Receiving only NIV
3. Under invasive mechanical ventilation previous to the 7-day period of inclusion
4. Transferred from another hospital under invasive mechanical ventilation
ICU: Intensive Care Unit; ER: Emergency Room; OR: Operating Room; NIV: Non-Invasive Ventilation
Table 1: Inclusion and exclusion criteria.
Time Within one week of a known clinical insult, or new/worsening respiratory symptoms
Chest imaging* Bilateral opacities not fully explained by effusions, lobar/lung collapse or nodules
Origin of edema Respiratory failure not fully explained by cardiac failure or fluid overload; need objective assessment to exclude hydrostatic edema if no risk factor present (e.g., echocardiography)
Oxygenation**
Mild
200 < PaO2 / FiO2 < 300 
PEEP or CPAP ≥ 5 cm H2O***
Moderate
100 < PaO2 / FiO2 < 200 
PEEP ≥ 5 cm H2O
Severe
PaO2 / FiO2 ≤ 100 
PEEP ≥ 5 cm H2O
ARDS: Acute Respiratory Distress Syndrome; PaO2: Partial Pressure Of Arterial Oxygen; FiO2: Inspired Fraction Of Oxygen; PEEP: Positive End-Expiratory Pressure; 
CPAP: Continuous Positive Airway Pressure
*: chest X-ray or CT scan
**: if altitude higher than 1,000 meters, correction factor should be made as follows: PaO2 / FiO2 9 (barometric pressure/760)
***: this may be delivered non-invasively in the mild ARDS group
Table 2: The Berlin definition of ARDS [12].
LIPS points LIPS points
Predisposing Conditions
   Shock
   Aspiration
   Sepsis
   Pneumonia
   High-risk surgery*
     Orthopedic spine
     Acute abdomen
     Cardiac
     Aortic vascular
   High-risk trauma
     Traumatic brain injury
     Smoke inhalation
     Near drowning
     Lung contusion
     Multiple fractures
2
2
1
1.5
1
2
2.5
3.5
2
2
2
1.5
1.5
Risk Modifiers
   Alcohol abuse
   Obesity (BMI > 30 kg/m2)
   Hypoalbuminemia
   Chemotherapy
   FiO2 > 0.35 (> 4 l/min)
   Tachypnea (RR > 30 bpm)
   SpO2 < 95%
   Acidosis (pH < 7.35)
   Diabetes mellitus**
1
1
1
1
2
1.5
1
1.5
-1
BMI: Body Mass Index; RR: Respiratory Rate; Fio2: Inspired Fraction Of Oxygen; SpO2: Oxygen Saturation By Pulse Oximetry
*: add 1.5 points if emergency surgery
**: only if sepsis
Table 3: Lung Injury Prediction Score (LIPS) calculation worksheet [13].
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injury, renal replacement therapy, sepsis, extra-pulmonary infection); 
7) number of ventilator-free days at day 28 and 90; 8) length of stay in 
ICU and in hospital at day 90; 9) all-cause ICU and hospital-mortality; 
10) all-cause mortality at day 90.
All-cause mortality is defined as any death during follow-up and 
length of stay as the time between admission and discharge or death. 
Days of ventilation is defined as time between orotracheal intubation 
and successful extubation (in case of intermittent mechanical 
ventilation via a tracheostomy, every day a patient needs ventilation 
counts as one extra day of ventilation, irrespective of duration of 
ventilation that specific day) In case of non-invasive ventilation, the 
duration will be assessed separated from the assessment of invasive 
mechanical ventilation. 
Pulmonary infection is defined as need of new antibiotics in the 
presence of new or changed lung opacities on chest X-ray and/or 
new or changed sputum plus at least one of the following criteria: 
1) temperature >38.3ºC; or 2) WBC count >12,000. Atelectasis is 
suggested by lung opacification with shift of the mediastinum, hilum, 
or hemidiaphragm towards the affected area, and compensatory 
overinflation in the adjacent nonatelectatic lung, while pleural effusion 
is suggest by lung opacification with shift of the mediastinum, hilum, or 
hemidiaphragm towards the non-affected area. Barotrauma is defined 
as the air in mediastinum or in the pleural space with no vascular bed 
surrounding the visceral pleura. ARDS is defined according to the 
Berlin definition and worsening of ARDS is defined as any change in 
the prior classification (i.e., mild to moderate or severe, or moderate 
to severe). Systemic Inflammatory Response Syndrome (SIRS), sepsis, 
severe sepsis, and septic shock is defined according to consensus criteria 
[13], and acute kidney injury according to the RIFLE classification 
system [14].
Statistical Analysis Plan
Sample size calculation 
The sample size is calculated for the largest and most relevant 
subgroup of the primary endpoint, the tidal volume size amongst 
patients without ARDS and also, expresses the number of patients 
needed to ensure that the margin of error is small enough to remain 
relevant for our objective. Experience a mean ± standard deviation tidal 
volume in patients without ARDS of 10 ± 2 ml/kg PBW, considering 
the incidence of 30% of ARDS in the population of interest [15], with 
95% confidence interval and a margin of error of 0.16, and corrected 
for 10% of drop-out, the net total sample size needed is 952 patients. 
To correct for drop-outs (incomplete follow–up, etc), we will include 
at least 1,000 patients
Analysis
Normally distributed variables will be expressed by their mean and 
standard deviation; not normally distributed variables will be expressed 
by their medians and interquartile ranges; categorical variables will be 
expressed as n (%). In test groups of continuous normally distributed 
variables, Student’s t-test will be used. Likewise if continuous data 
are not normally distributed the Mann-Whitney U test will be used. 
Categorical variables will be compared with the Chi-square test or 
Fisher’s exact tests or when appropriate as relative risks. Statistical 
uncertainty will be expressed by 95% confidence levels.
Primary outcome is the tidal volume size in each group within 
mechanical ventilation, presented as milliliters per kilogram of 
predicted body weight (ml/kg PBW). The ml/kg PBW will be analyzed 
as continuous variables. If the data is normally distributed, one-way 
Analysis Of Variance (ANOVA) or two-way ANOVA assessing the 
time-interaction between groups and days of observation will be used. 
When not normally distributed the Kruskal-Wallis test or Friedman 
test assessing the time-interaction between groups and days of 
observation will be used.
Propensity score is calculated by a multivariate logistic regression 
model with outcome as the dependent variable, while all other 
covariates related to mortality is included as independent variable. 
Tidal volume size related to outcomes is investigated using conditional 
logistic regression. Also, a Cox proportional hazards model with 
outcomes as dependent variables and tidal volume and propensity score 
as covariates is used. Time-course variables (e.g., repeated measures of 
ventilatory parameters, vital signs, oxygenation parameters and others) 
are also analyzed by a linear mixed model. The linear mixed models 
procedure expands the Generalized Linear Model (GLM) so that the 
data are permitted to exhibit correlated and non-constant variability. 
The model includes two factors: 1) study group (fixed factor), each level 
of the study group factor can have a different linear effect on the value 
of the dependent variable; 2) time as covariate, time is considered to 
be a random sample from a larger population of values, the effect is 
not limited to the chosen times. Pre-specified subgroup analyses will 
be performed in the following subgroups: 1) ARDS vs. Non-ARDS; 2) 
severity of ARDS; 3) reason for ICU admission; 4) reason for intubation 
and mechanical ventilation; and 5) at risk or not for ARDS (according 
to LIPS).
Statistical significance is considered to be at a p-value of <0.05. 
Statistical analyses are conducted using SPSS version 20.0 (SPSS, Inc., 
Chicago, IL).
 Study Organization
The study coordinator, the principal investigator and two 
additional investigators of PROVENet (http://www.provenet.eu/) form 
the Core Steering Committee. The Steering Committee is composed 
of these investigators plus the investigators involved in the design of 
the study and writing of the study protocol. National Coordinators are 
responsible for administrative management and communication with 
local Coordinators (in participating hospitals) and provide assistance 
to the participating clinical sites in study management, record keeping 
and data management. National Coordinators and local Coordinators 
are expected to guarantee the quality and security of the data collected.
Discussion
PRoVENT is an international multi-center prospective 
observational study that aims to determine ventilation practice and 
outcomes of consecutive intubated and ventilated ICU patients in a 
7-day period in ICUs in Europe, Australia and the Americas. PRoVENT 
will help to understand current mechanical ventilation practice, in 
particular variability in tidal volume size, amongst patients without, at 
risk for or with ARDS. Results of this study can and should be used 
to plan future studies of mechanical ventilation in ICU patients. The 
sample size of PRoVENT will have power to determine the current 
practice of ventilation and the tidal volume size in several subgroups of 
mechanically ventilated patients, like those without ARDS, those at risk 
for ARDS and those in each severity group of ARDS.
Several observational studies in ICU patients under mechanical 
ventilation have been published in recent years (Table 4) [1,4,15-23]. 
Differences in reported tidal volume sizes between studies are large, but 
there is a suggestion that lower tidal volumes are increasingly used over 
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the last years. Previous studies lack important information, first, patient 
populations studied are heterogeneous, and most of the published 
analyses do not allow conclusions regarding ventilation practices in 
specific patient groups (i.e. patients without ARDS, patients at risk for 
ARDS, and patients with mild, moderate or severe ARDS). Furthermore, 
common to all previous studies, the publications do not report analyses 
of effects of tidal volume size on important clinical outcome measures. 
This information is crucial for future trials of mechanical ventilation 
in ICU patients. Indeed, we need to know which patients other than 
those with ARDS would benefit from the use of lower tidal volumes. 
Second, for power calculations information is needed with regard to the 
primary endpoint (e.g., incidence of development of ARDS, duration 
of mechanical ventilation, or death) of patient groups of interest in 
planning any trial. Third, we need to know what tidal volumes are used 
in groups of interest, to choose the appropriate tidal volume size in 
the control groups of future trials. PRoVENT is the first observational 
study that can provide this information.
It can be difficult and sometimes even impossible to distinguish 
patients without ARDS from those with mild ARDS, since previously 
used criteria (i.e., the American-European Consensus Criteria [24]) and 
present definition (i.e., the Berlin definition [11]) lack sufficient power 
to discriminate between patients at risk for ARDS or with mild ARDS, 
and between patients with mild ARDS and patients with moderate or 
severe ARDS [12,25]. Notably, none of the published studies so far 
used the new definition for ARDS [11]. Since ventilation with lower 
tidal volumes is well established in patients with the syndrome, failure 
to identify patients with mild ARDS can lead to the use of higher 
tidal volumes in this group of patients, potentially worsening their 
outcomes. The use of lower tidal volumes for all patients can potentially 
avoid this situation. Also, recent studies show that median tidal volume 
size in all subgroup of patients (without and with ARDS) was well 
above 6 ml/kg PBW. The reasons for lack of adherence to a lower tidal 
volume strategy may include concerns about adverse effects of low 
tidal volumes, such as hypercapnia and increased need for sedatives, 
insufficient knowledge of the lung protective ventilation protocols and 
under recognition of ARDS [15,26].
Despite the benefits associated with use of lower tidal volumes, there 
are some possible side effects. Use of lower tidal volumes may increases 
the need for sedation and even neuromuscular blockade, increasing the 
risk of delirium and the rate of ICU-acquired paresis [10]. Also, the 
use of lower levels of assistance could exhaust the respiratory muscles, 
leading to increased duration of mechanical ventilation [10]. Previous 
studies did not confirm these effects, since the use of lower tidal volume 
did not increase the need of sedation [27] and could be associated with 
a shorter hospital length of stay [9]. Well-powered, probably large, 
studies are needed to definitively answer these questions. 
Recently, much attention has been drawn to the role of driving 
pressure (plateau pressure or maximal airway pressure minus PEEP) in 
development of ventilator-associated lung injury. Some reports suggest 
that higher driving pressure levels are associated with worse outcome 
of patients with ARDS [28-30]. With data of PRoVENT, by building a 
predictive model, and with the use of multivariate analyses, it could be 
possible to discriminate the effects of tidal volume size versus driving 
pressure on patient’s outcomes.
In conclusion, PRoVENT is an international multicenter 
observational study powered to investigate the tidal volume size 
actually used and the outcomes of ICU-patients intubated and under 
mechanical ventilation without ARDS, without ARDS but at risk for, 
and with mild, moderate or severe ARDS. 
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Tidal volume corrected by the predicted body weight in 15, 19, 22, 23, and 24 by the actual body weight in 20, 21, and 25 and not reported in 16, 17, and 18
MV: Mechanical Ventilation; VT: Tidal Volume; ARF: Acute Respiratory Failure; M/S: Moderate/Severe; PBW: Predicted Body Weight; ARDS: Acute Respiratory Distress 
Syndrome
*since these studies collected data before implementation of the Berlin definition, it reports the tidal volume in acute lung injury that we changed to mild ARDS here
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